← All trials
NCT06368063
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 6, 2024
- Primary completion
- Mar 31, 2026
- Completion date
- Mar 31, 2028
- First posted
- Apr 16, 2024
- Last posted
- May 8, 2024
- Enrollment
- 642
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Jiao Tong UniversityLead sponsor
- Jiao Tong UniversityOfficial
- Huazhong University of Science and TechnologyCollaborator
- Jiao Tong UniversitySponsor investigator
- LinkDoc Technology (Beijing) Co. Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.